SEARCH

SEARCH BY CITATION

References

  • 1
    Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2000; 50: 3449.
  • 2
    Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin 2001; 51: 3875; quiz 77–80.
  • 3
    Smith RA, Cokkinides V, von Eschenbach AC, et al. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002; 52: 822.
  • 4
    Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003; 53: 2743.
  • 5
    Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 2004; 54: 4152.
  • 6
    Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guidelines for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52: 342362.
  • 7
    Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003; 53: 141169.
  • 8
    Levin B, Brooks D, Smith RA, Stone A. Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin 2003; 53: 4455.
  • 9
    Baxter N. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? Can Med Assoc J 2001; 164: 18371846.
  • 10
    Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002; 94: 14451457.
  • 11
    Smith R. Commentary: breast self examination: do we really know what we think we know? Br Med J USA 2003; 327: 168169.
  • 12
    Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351: 427437.
  • 13
    Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004; 292: 13171325.
  • 14
    Pitts M, Clarke T. Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res 2002; 17: 706714.
  • 15
    Waller J, McCaffery K, Forrest S, et al. Awareness of human papillomavirus among women attending a well woman clinic. Sex Transm Infect 2003; 79: 320322.
  • 16
    Centers for Disease Control and Prevention. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR Morbid Mortal Wkly Rep 1995; 44: 134.
  • 17
    US Preventive Services Task Force. Summaries for patients. Screening for colorectal cancer: recommendations from the United States Preventive Services Task Force. Ann Intern Med 2002; 137: I38.
  • 18
    Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology 2003; 124: 544560.
  • 19
    Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening Practices. Am J Med 2003; 115: 129133.
  • 20
    Ransohoff DF. Screening colonoscopy in balance. Issues of implementation. Gastroenterol Clin North Am 2002; 31: 10311044, vii.
  • 21
    Ahlquist DA. Stool-based DNA tests for colorectal cancer: clinical potential and early results. Rev Gastroenterol Disord 2002; 2(Suppl 1)): S20S26.
  • 22
    Pickhardt PJ, Choi, Jr, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349: 21912200.
  • 23
    Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med 1999; 14: 432437.
  • 24
    Vernon SW. Participation in colorectal cancer screening: a review [see comments]. J Natl Cancer Inst 1997; 89: 14061422.
  • 25
    Pignone M, Saha S, Hoerger T, Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the US Preventive Services Task Force. Ann Intern Med 2002; 137: 96104.
  • 26
    Mysliwiec PA, Brown ML, Klabunde CN, Ransohoff DF. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy. Ann Intern Med 2004; 141: 264271.
  • 27
    Baron TH, Kimery BD, Sorbi D, et al. Strategies to address increased demand for colonoscopy: guidelines in an open endoscopy practice. Clin Gastroenterol Hepatol 2004; 2: 178182.
  • 28
    Walker JL, Nunez ER. Endometrial Cancer, in Kramer BS, Gohagan JK, Prorok PC (eds). Cancer Screening: Theory and Practice. New York: Marcel Dekker, Inc.; 1999: 531566.
  • 29
    American Cancer Society. Guidelines for the cancer related checkup: recommendations and rationale. CA Cancer J Clin 1980; 30: 450.
  • 30
    Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: overall design and findings from baseline screening [see comments]. Lancet 1999; 354: 99105.
  • 31
    Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362: 593597.
  • 32
    Ford LG, Minasian LM, McCaskill-Stevens W, et al. Prevention and early detection clinical trials: opportunities for primary care providers and their patients. CA Cancer J Clin 2003; 53: 82101.
  • 33
    Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies [see comments]. BMJ 2000; 321: 323329.
  • 34
    Eyre H, Kahn R, Robertson RM. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. CA Cancer J Clin 2004; 54: 190207.
  • 35
    Eyre H, Kahn R, Robertson RM, et al. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation 2004; 109: 32443255.
  • 36
    Eyre H, Kahn R, Robertson RM, et al. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Stroke 2004; 35: 19992010.
  • 37
    Eyre H, Kahn R, Robertson RM. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Diabetes Care 2004; 27: 18121824.
  • 38
    Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1979; 121: 11931254.
  • 39
    Ruffin MT, Gorenflo DW, Woodman B. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. J Am Board Fam Pract 2000; 13: 110.
  • 40
    Smith RA, Wender RC. Cancer screening and the periodic health examination. Cancer 2004; 100: 15531557.
  • 41
    Centers for Disease Control and Prevention. Behavioral Risk Factor Survey. Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention; 2002.
  • 42
    Shah B, Barnwell B, Bieler G. SUDAAN: Professional Software for Survey Data Analysis: User Documentation for Release 8.0. Research Triangle Park, NC: Research Triangle Institute; 1997.
  • 43
    Saraiya M, Hall I, Thompson T, et al. Skin cancer screening among US adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med 2004; 39: 308314.
  • 44
    Madelblatt J, Yabroff K, Kerner J. Equitable access to cancer services: a review of barriers to quality care. Cancer 1999; 86: 23782390.
  • 45
    Zapka J, Taplin S, Solberg L, Manos M. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev 2003; 12: 413.
  • 46
    Blustein J. Medicare coverage, supplemental insurance, and the use of mammography by older women. N Engl J Med 1995; 332: 11381143.
  • 47
    Potosky AL, Breen N, Graubard BI, Parsons PE. The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med Care 1998; 36: 257270.
  • 48
    Bazargan M, Bazargan S, Farooq M, Baker R. Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med 2004; 39: 465473.
  • 49
    Hewitt M, Devessa S, Breen N. Cervical cancer screening among US women: analyses of the 2000 National Health Interview Survey. Prev Med 2004; 39: 270278.
  • 50
    Petersen G. Barriers to preventive intervention. Gastroenterol Clin North Am 2002; 31: 10611068.
  • 51
    Lambrew JM, Defriese GH, Carey TS, et al. The effects of having a regular doctor on access to primary care. Med Care 1996; 34: 138151.
  • 52
    Coughlin S, Uhler R, Bobo J, Caplan L. Breast cancer screening practices among women in the United States, 2000. Cancer Causes Control 2004; 15: 159170.
  • 53
    Seeff L, Nadel M, Klabunde C, et al. Patterns and predictors of colorectal cancer test use in the adult US population. Cancer 2004; 100: 20932103.
  • 54
    Coronado G, Thompson B, Koepsell T, et al. Use of Pap test among Hispanics and non-Hispanic whites in a rural setting. Prev Med 2004; 38: 713722.
  • 55
    Ross L, Coates R, Breen N, et al. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med 2004; 38: 732744.
  • 56
    Mills R, Bhandari S. Health Insurance Coverage in the United States: 2002. Washington, DC: US Government Printing Office; 2003. US Census Bureau Current Population Reports, P60-223.
  • 57
    US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. 2nd ed. Washington, DC: US Government Printing Office, 2000.
  • 58
    Roetzheim R, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999; 91: 14091415.
  • 59
    Bradley C, Given C, Roberts C. Late stage cancers in a Medicaid-insured population. Med Care 2003; 41: 722728.
  • 60
    Institute of Medicine. Ensuring Quality of Cancer Care. Washington, DC: National Academy Press; 1999.
  • 61
    Taplin SH, Ichikawa L, Buist DS, et al. Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev 2004; 13: 225234.
  • 62
    Curry SJ, Byers T, Hewitt M, eds. Fulfilling the Potential of Cancer Prevention and Early Detection. Washington, DC: National Academy Press; 2003.